HK Stock MarketDetailed Quotes
01873 VIVA BIOTECH
- 0.940
- -0.010-1.05%
Trading Nov 8 11:12 CST
2.01BMarket Cap-15932P/E (TTM)
0.980High0.930Low359.00KVolume0.980Open0.950Pre Close343.76KTurnover0.02%Turnover RatioLossP/E (Static)2.14BShares1.27052wk High0.49P/B2.01BFloat Cap0.41052wk Low--Dividend TTM2.14BShs Float11.640Historical High--Dividend LFY5.26%Amplitude0.410Historical Low0.957Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
VIVA BIOTECH Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 404.78%185.52M | 87.81%-55.95M | 157.90%36.75M | -232.06%-459.17M | -152.00%-63.47M | 197.61%347.7M | 123.36%122.05M | -226.80%-356.21M | -983.08%-522.39M | 165.37%280.93M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 32.52%-9.01M | -26.70%-27.38M | -22.28%-13.34M | 18.70%-21.61M | 32.51%-10.91M | -59.04%-26.58M | -105.97%-16.17M | -10.76%-16.71M | -12.24%-7.85M | -1,652.15%-15.09M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.45M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -74.48%487K | -65.96%321K | -41.22%1.91M |
| Impairment and provisions: | 1,236.69%7.43M | 21.95%19.49M | -88.57%556K | 355.36%15.98M | 797.60%4.87M | 21.24%3.51M | 24.88%542K | 59.77%2.9M | -67.22%434K | 1,503.54%1.81M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---134K | ---- | ---- |
| -Other impairments and provisions | 1,236.69%7.43M | 21.95%19.49M | -88.57%556K | 355.36%15.98M | 797.60%4.87M | 15.88%3.51M | 24.88%542K | 67.16%3.03M | -67.22%434K | 1,503.54%1.81M |
| Revaluation surplus: | -1,493.27%-68.67M | -135.48%-140.16M | -119.66%-4.31M | 315.71%395.07M | 140.12%21.92M | -144.77%-183.15M | -109.98%-54.64M | 323.09%409.13M | 4,029.99%547.45M | -285.05%-183.39M |
| -Fair value of investment properties (increase) | ---- | --13.82M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Derivative financial instruments fair value (increase) | -142.78%-4.24M | -78.84%8.66M | -54.41%9.91M | 128.51%40.94M | 348.32%21.73M | -127.82%-143.59M | -515.90%-8.75M | --516.07M | ---1.42M | ---- |
| -Other fair value changes | -353.17%-64.43M | -145.93%-162.64M | -7,744.09%-14.22M | 995.14%354.13M | 100.41%186K | 63.01%-39.56M | -108.36%-45.89M | 41.69%-106.94M | 4,040.19%548.87M | -285.05%-183.39M |
| Asset sale loss (gain): | 1,168.42%241K | -114.94%-284K | -97.54%19K | 140.91%1.9M | -85.61%771K | 39.19%-4.65M | 641.11%5.36M | 34.44%-7.64M | 89.98%-990K | 28.78%-11.66M |
| -Loss (gain) from sale of subsidiary company | ---- | ---683K | ---- | ---- | ---- | ---9.49M | ---- | ---- | ---- | -188.71%-11.68M |
| -Loss (gain) on sale of property, machinery and equipment | 1,168.42%241K | -80.68%399K | -97.76%19K | -62.64%2.07M | -84.13%850K | 1,924.91%5.53M | 3,356.13%5.36M | 780.65%273K | 1,092.31%155K | 720.00%31K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | 76.20%-164K | ---79K | 91.30%-689K | ---- | -263,733.33%-7.92M | ---1.15M | 99.98%-3K |
| Depreciation and amortization: | -5.70%103.98M | 13.89%211.22M | 19.74%110.26M | 21.09%185.45M | 24.92%92.09M | 118.21%153.15M | 242.16%73.72M | 106.16%70.19M | 62.58%21.54M | 256.56%34.04M |
| -Depreciation | ---- | -0.08%55.55M | ---- | 6.18%55.6M | 12.83%27.75M | 752.96%52.36M | --24.59M | --6.14M | ---- | ---- |
| -Amortization of intangible assets | 0.09%27.81M | ---- | --27.78M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial expense | -64.37%31.35M | -4.38%176.58M | -1.25%87.98M | 0.86%184.67M | -7.28%89.1M | 194.70%183.11M | 148.99%96.1M | 2,648.08%62.13M | 4,325.92%38.59M | --2.26M |
| Exchange Loss (gain) | -87.88%3.63M | -80.47%34.79M | -69.52%29.92M | 27,687.21%178.12M | 4,073.26%98.16M | -88.69%641K | 131.52%2.35M | 173.48%5.67M | -623.06%-7.46M | -67.56%-7.72M |
| Special items | -774.15%-22.79M | 5,198.46%214.01M | 115.26%3.38M | 104.53%4.04M | 34.11%-22.16M | -111.69%-89.25M | -27.95%-33.63M | -13.83%-42.16M | -23.92%-26.29M | -191.33%-37.04M |
| Operating profit before the change of operating capital | -7.78%231.68M | -10.76%432.32M | 19.43%251.22M | 26.00%484.46M | 7.50%210.35M | 211.74%384.49M | 351.30%195.68M | 86.70%123.34M | 92.72%43.36M | 77.82%66.06M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -31.95%33.02M | 159.15%57.04M | 347.30%48.53M | -39.63%-96.44M | -225.91%-19.62M | -6,793.51%-69.07M | 1,468.22%15.58M | 72.40%-1M | -280.94%-1.14M | -130.18%-3.63M |
| Accounts receivable (increase)decrease | -123.26%-22.58M | 236.44%30.44M | 377.18%97.06M | 77.36%-22.31M | 69.22%-35.02M | -137.23%-98.51M | -1,199.45%-113.75M | -428.60%-41.53M | -236.72%-8.75M | 73.01%-7.86M |
| Accounts payable increase (decrease) | -0.67%-24.56M | -138.89%-29.54M | -46.20%-24.4M | 204.97%75.97M | 67.13%-16.69M | -801.23%-72.37M | -894.63%-50.77M | -21.18%10.32M | -225.93%-5.1M | 21.28%13.09M |
| prepayments (increase)decrease | ---- | -116.51%-6.4M | ---- | 268.53%38.73M | ---- | 41.86%-22.98M | ---- | -1,136.53%-39.53M | ---- | ---3.2M |
| Special items for working capital changes | -240.98%-10.49M | -45.32%-20.13M | 325.65%7.44M | -1,077.49%-13.85M | 69.98%-3.3M | -83.82%1.42M | -3,701.97%-10.99M | 504.34%8.76M | 110.53%305K | -43,220.00%-2.17M |
| Cash from business operations | -45.49%207.07M | -0.61%463.73M | 179.87%379.85M | 279.39%466.56M | 279.58%135.72M | 103.76%122.98M | 24.73%35.76M | -3.13%60.35M | 18.75%28.67M | 275.12%62.31M |
| Other taxs | 12.28%-54.74M | 0.22%-80.33M | -44.75%-62.4M | -78.33%-80.51M | -144.23%-43.11M | -162.88%-45.15M | -128.30%-17.65M | -5.39%-17.17M | 33.16%-7.73M | -262.11%-16.3M |
| Net cash from operations | -52.01%152.33M | -0.69%383.41M | 242.75%317.45M | 396.02%386.05M | 411.53%92.62M | 80.24%77.83M | -13.52%18.11M | -6.15%43.18M | 66.49%20.94M | 279.95%46.01M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 34.71%8.98M | 497.36%56.37M | 26.55%6.66M | -21.59%9.44M | -39.74%5.27M | -17.26%12.04M | 50.90%8.74M | -2.41%14.55M | -16.32%5.79M | 1,446.06%14.9M |
| Loan receivable (increase) decrease | --41.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | --130M | --500M | ---- | ---- | ---- | ---- | ---- | -30,257.18%-644.46M | -19,652.61%-419.6M | --2.14M |
| Sale of fixed assets | -53.70%125K | -1.82%648K | 13,400.00%270K | -58.15%660K | -99.50%2K | 1,094.70%1.58M | 1,150.00%400K | 169.39%132K | 300.00%32K | -24.62%49K |
| Purchase of fixed assets | -26.32%-128.35M | 24.73%-187.68M | 25.66%-101.61M | 55.89%-249.33M | 38.00%-136.68M | -182.51%-565.18M | -348.83%-220.44M | -256.05%-200.06M | -214.13%-49.11M | -19.80%-56.19M |
| Purchase of intangible assets | -174.84%-437K | 26.17%-158K | ---159K | 81.31%-214K | ---- | 99.73%-1.15M | ---1.15M | -7,309.22%-417.81M | ---- | ---5.64M |
| Sale of subsidiaries | --12M | --32.34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | 61.49%-81.2M | ---- | 91.55%-210.87M | -127.50%-126.96M | ---2.49B | ---55.81M | ---- |
| Recovery of cash from investments | 298.74%144.06M | -28.79%117.4M | 6.15%36.13M | -91.68%164.88M | -96.49%34.04M | -41.38%1.98B | -62.83%969.24M | 108.80%3.38B | --2.61B | 2,331.71%1.62B |
| Cash on investment | 39.19%-13.27M | 60.15%-92.95M | 74.26%-21.82M | 88.92%-233.23M | 94.28%-84.77M | 39.55%-2.1B | 46.01%-1.48B | -93.14%-3.48B | -4,505.53%-2.75B | -1,682.58%-1.8B |
| Other items in the investment business | 160.44%6.59M | -18.52%13.2M | -619.05%-10.9M | -4.51%16.2M | 110.00%2.1M | 325.47%16.96M | -80.77%1M | 87.92%-7.52M | 108.00%5.2M | -13,160.80%-62.3M |
| Net cash from investment operations | 320.50%201.59M | 217.80%439.17M | 49.22%-91.43M | 57.09%-372.8M | 78.85%-180.05M | 77.43%-868.84M | -30.73%-851.46M | -1,227.04%-3.85B | -922.81%-651.29M | -314.67%-290.06M |
| Net cash before financing | 56.59%353.92M | 6,109.55%822.58M | 358.52%226.02M | 101.67%13.25M | 89.51%-87.43M | 79.22%-791.01M | -32.20%-833.35M | -1,459.55%-3.81B | -1,133.53%-630.36M | -321.94%-244.04M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 578.17%972.43M | 141.20%1.62B | -52.40%143.39M | 19.12%673.04M | 16.31%301.25M | -61.34%565.03M | 1,585.87%259M | 6,983.68%1.46B | 44.51%15.36M | --20.63M |
| Refund | -870.94%-1.33B | -136.68%-1.04B | 45.40%-137.26M | 55.04%-438.61M | 72.38%-251.38M | -3,665.75%-975.55M | -351,344.02%-910.24M | -22.62%-25.91M | 97.62%-259K | -37.25%-21.13M |
| Issuing shares | ---- | --421.86M | ---- | ---- | ---- | -99.55%18.23M | -99.60%5.18M | 200.97%4.05B | -3.89%1.29B | 573.02%1.35B |
| Interest paid - financing | 9.93%-31.25M | 2.97%-70.69M | 0.30%-34.69M | -2.22%-72.86M | 14.22%-34.79M | -502.29%-71.28M | -18,505.96%-40.56M | -4,009.03%-11.83M | -257.38%-218K | 48.29%-288K |
| Dividends paid - financing | ---- | ---20M | ---- | ---- | ---- | 48.73%-26.55M | ---10.28M | 61.87%-51.79M | ---- | ---135.84M |
| Absorb investment income | --39.53M | --1.14B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | -509.57%-1.84B | -61.38%-46.54M | -102.84%-302.31M | 59.81%-28.84M | -50.34%-149.04M | -55.53%-71.75M | 52.48%-99.14M | 33.81%-46.14M | -4,522.51%-208.61M |
| Other items of the financing business | ---- | -28,941.62%-640.28M | --217.21M | 2,236.84%2.22M | ---- | --95K | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -352.12%-354.61M | -199.94%-429.5M | 950.03%140.65M | 78.08%-143.2M | 97.87%-16.55M | -112.31%-653.16M | -162.57%-776.11M | 438.88%5.31B | 8.44%1.24B | 448.73%984.86M |
| Effect of rate | -97.85%611K | -566.57%-35.32M | 86.31%28.37M | 111.95%7.57M | 150.76%15.23M | 34.64%-63.34M | -515.69%-29.99M | -1,355.90%-96.91M | 599.13%7.22M | 86.02%7.72M |
| Net Cash | -100.19%-692K | 402.49%393.08M | 452.65%366.68M | 91.00%-129.95M | 93.54%-103.98M | -196.20%-1.44B | -363.86%-1.61B | 102.65%1.5B | -44.18%609.98M | 509.03%740.82M |
| Begining period cash | 52.72%1.04B | -15.28%678.57M | -15.28%678.57M | -65.30%800.95M | -65.30%800.95M | 155.33%2.31B | 155.33%2.31B | 481.21%904.09M | 481.21%904.09M | 422.59%155.55M |
| Items Period | ---407K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash at the end | -3.52%1.04B | 52.72%1.04B | 50.75%1.07B | -15.28%678.57M | 6.46%712.2M | -65.30%800.95M | -56.02%669M | 155.33%2.31B | 21.77%1.52B | 481.21%904.09M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data